11-36493742-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004620.4(TRAF6):​c.679-1114C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0133 in 152,234 control chromosomes in the GnomAD database, including 32 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.013 ( 32 hom., cov: 32)

Consequence

TRAF6
NM_004620.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.196

Publications

1 publications found
Variant links:
Genes affected
TRAF6 (HGNC:12036): (TNF receptor associated factor 6) The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins are associated with, and mediate signal transduction from, members of the TNF receptor superfamily. This protein has an amino terminal RING domain which is followed by four zinc-finger motifs, a central coiled-coil region and a highly conserved carboxyl terminal domain, known as the TRAF-C domain and mediates signaling from members of the TNF receptor superfamily as well as the Toll/IL-1 family. Signals from receptors such as CD40, TNFSF11/RANCE and IL-1 have been shown to be mediated by this protein. This protein also interacts with various protein kinases including IRAK1/IRAK, SRC and PKCzeta, which provides a link between distinct signaling pathways. This protein functions as a signal transducer in the NF-kappaB pathway that activates IkappaB kinase (IKK) in response to proinflammatory cytokines. The interaction of this protein with UBE2N/UBC13, and UBE2V1/UEV1A, which are ubiquitin conjugating enzymes catalyzing the formation of polyubiquitin chains, has been found to be required for IKK activation by this protein. This protein also interacts with the transforming growth factor (TGF) beta receptor complex and is required for Smad-independent activation of the JNK and p38 kinases. The protein encoded by this gene is a key molecule in antiviral innate and antigen-specific immune responses. [provided by RefSeq, Nov 2021]
TRAF6 Gene-Disease associations (from GenCC):
  • autosomal dominant hypohidrotic ectodermal dysplasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0637 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004620.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TRAF6
NM_004620.4
MANE Select
c.679-1114C>G
intron
N/ANP_004611.1
TRAF6
NM_145803.3
c.679-1114C>G
intron
N/ANP_665802.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TRAF6
ENST00000526995.6
TSL:1 MANE Select
c.679-1114C>G
intron
N/AENSP00000433623.1
TRAF6
ENST00000348124.5
TSL:1
c.679-1114C>G
intron
N/AENSP00000337853.5
TRAF6
ENST00000529150.1
TSL:5
n.224-1114C>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0133
AC:
2019
AN:
152116
Hom.:
32
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00333
Gnomad AMI
AF:
0.0384
Gnomad AMR
AF:
0.0162
Gnomad ASJ
AF:
0.0216
Gnomad EAS
AF:
0.0697
Gnomad SAS
AF:
0.0230
Gnomad FIN
AF:
0.00245
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0146
Gnomad OTH
AF:
0.0120
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0133
AC:
2019
AN:
152234
Hom.:
32
Cov.:
32
AF XY:
0.0130
AC XY:
965
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.00332
AC:
138
AN:
41546
American (AMR)
AF:
0.0162
AC:
248
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.0216
AC:
75
AN:
3470
East Asian (EAS)
AF:
0.0697
AC:
361
AN:
5182
South Asian (SAS)
AF:
0.0230
AC:
111
AN:
4820
European-Finnish (FIN)
AF:
0.00245
AC:
26
AN:
10602
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0146
AC:
996
AN:
68014
Other (OTH)
AF:
0.0118
AC:
25
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
99
198
298
397
496
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0119
Hom.:
1
Bravo
AF:
0.0150
Asia WGS
AF:
0.0330
AC:
113
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
6.6
DANN
Benign
0.61
PhyloP100
-0.20
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5030504; hg19: chr11-36515292; API